These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1690554)

  • 1. Substance P immunoreactivity in Alzheimer disease: a study in cases presenting symmetric or asymmetric cortical atrophy.
    Bouras C; Vallet PG; Hof PR; Charnay Y; Golaz J; Constantinidis J
    Alzheimer Dis Assoc Disord; 1990; 4(1):24-34. PubMed ID: 1690554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different mechanisms of corpus callosum atrophy in Alzheimer's disease and vascular dementia.
    Tomimoto H; Lin JX; Matsuo A; Ihara M; Ohtani R; Shibata M; Miki Y; Shibasaki H
    J Neurol; 2004 Apr; 251(4):398-406. PubMed ID: 15083283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance P-like immunoreactivity in brains with pathological features of Parkinson's and Alzheimer's diseases.
    Clevens RA; Beal MF
    Brain Res; 1989 May; 486(2):387-90. PubMed ID: 2471578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plaque-associated neuronal proteins: a recurrent motif in neuritic amyloid deposits throughout diverse cortical areas of the Alzheimer's disease brain.
    Schmidt ML; DiDario AG; Otvos L; Hoshi N; Kant JA; Lee VM; Trojanowski JQ
    Exp Neurol; 1994 Dec; 130(2):311-22. PubMed ID: 7867760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease.
    Lidström AM; Bogdanovic N; Hesse C; Volkman I; Davidsson P; Blennow K
    Exp Neurol; 1998 Dec; 154(2):511-21. PubMed ID: 9878186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-I and its receptor in the frontal cortex, hippocampus, and cerebellum of normal human and alzheimer disease brains.
    Jafferali S; Dumont Y; Sotty F; Robitaille Y; Quirion R; Kar S
    Synapse; 2000 Dec; 38(4):450-9. PubMed ID: 11044892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance P-like immunoreactivity is reduced in Alzheimer's disease cerebral cortex.
    Beal MF; Mazurek MF
    Neurology; 1987 Jul; 37(7):1205-9. PubMed ID: 2439949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases.
    Joachim CL; Morris JH; Selkoe DJ
    Ann Neurol; 1988 Jul; 24(1):50-6. PubMed ID: 3415200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Various quantitative characteristics of the pathoarchitectonics of the cerebral cortex in Pick disease and Alzheimer disease].
    Preobrazhenskaia NS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(7):969-73. PubMed ID: 4036430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha 1-trypsin immunoreactivity in Alzheimer disease.
    Smith MA; Kalaria RN; Perry G
    Biochem Biophys Res Commun; 1993 Jun; 193(2):579-84. PubMed ID: 8512558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional distribution of amino acid transmitters in postmortem brains of presenile and senile dementia of Alzheimer type.
    Sasaki H; Muramoto O; Kanazawa I; Arai H; Kosaka K; Iizuka R
    Ann Neurol; 1986 Mar; 19(3):263-9. PubMed ID: 2870679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A disorganized increase of galanin-like immunoreactivity in cerebral cortex of Alzheimer-type dementia brains.
    Minami M; Makino Y; Arai H; Iizuka R
    J Neural Transm Park Dis Dement Sect; 1991; 3(4):285-92. PubMed ID: 1722980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The possible role of capillary cerebral amyloid angiopathy in Alzheimer lesion development: a regional comparison.
    Jeynes B; Provias J
    Acta Neuropathol; 2006 Oct; 112(4):417-27. PubMed ID: 16830133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications.
    Papasozomenos SC
    Lab Invest; 1989 Jan; 60(1):123-37. PubMed ID: 2492060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated cortical zinc in Alzheimer disease.
    Religa D; Strozyk D; Cherny RA; Volitakis I; Haroutunian V; Winblad B; Naslund J; Bush AI
    Neurology; 2006 Jul; 67(1):69-75. PubMed ID: 16832080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression of COX-2 in subdivisions of the hippocampus during aging and in Alzheimer's disease: the Hisayama Study.
    Fujimi K; Noda K; Sasaki K; Wakisaka Y; Tanizaki Y; Iida M; Kiyohara Y; Kanba S; Iwaki T
    Dement Geriatr Cogn Disord; 2007; 23(6):423-31. PubMed ID: 17457030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytoarchitectonic characteristics of the fields of the human cerebral cortex in Alzheimer's disease and senile dementia].
    Bogolepova IN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(7):39-44. PubMed ID: 3188773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capillary beds are decreased in Alzheimer's disease, but not in Binswanger's disease.
    Kitaguchi H; Ihara M; Saiki H; Takahashi R; Tomimoto H
    Neurosci Lett; 2007 May; 417(2):128-31. PubMed ID: 17403574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.
    Ferrer I; Barrachina M; Puig B; Martínez de Lagrán M; Martí E; Avila J; Dierssen M
    Neurobiol Dis; 2005 Nov; 20(2):392-400. PubMed ID: 16242644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.